Clinical Trial Update: Adjunctive Ziprasidone in the Treatment of Bipolar I Depression [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating adjunctive Ziprasidone for Bipolar I Depression has completed; results were posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Depression Bipolar

Drugs mentioned

• Ziprasidone (ziprasidone)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Bipolar Disorder, Depression, Bipolar | Phase 3 | Status: COMPLETED | Results posted: 2010-02-23